Auto-immune liver diseases and their treatment
Hess, J.; Thorens, J.; Pache, I.; Troillet, F.X.; Moradpour, D.; Gonvers, J.J.
Revue Medicale Suisse 1(3): 242; 245-247
2005
ISSN/ISBN: 1660-9379 PMID: 15770819 Document Number: 584988
There are three main types of auto-immune liver disease, auto-immune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis. In the case of auto-immune hepatitis, prednisone therapy, with or without azathioprine, can improve quality of life and halt progression to cirrhosis. If there is no response or if the therapy is poorly tolerated, mycophenolate mofetil or cyclosporin should be considered. Ursodeoxycholic acid (UDCA), at a dosage of 13 to 15 mg/kg/day slows the progression of fibrosis in patients with primary biliary cirrhosis. Pruritus may be treated with cholestyramine, rifampicin or opiate antagonists. Ursodeoxycholic acid at a dosage of 20 to 30 mg/kg/day will slow the evolution of fibrosis.